4//SEC Filing
MALKIEL BURTON G 4
Accession 0001179110-19-005457
CIK 0001583107other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 6:21 PM ET
Size
7.6 KB
Accession
0001179110-19-005457
Insider Transaction Report
Form 4
MALKIEL BURTON G
Director
Transactions
- Award
Share Option (Right to Buy)
2019-04-30+6,000→ 6,000 totalExercise: $23.85Exp: 2029-04-29→ Ordinary Shares (6,000 underlying) - Award
Ordinary Shares
2019-04-30+8,385→ 65,142 total
Holdings
- 15,000(indirect: By Spouse)
Ordinary Shares
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001184677
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 6:21 PM ET
- Size
- 7.6 KB